Curaleaf Holdings (CURLF) Operating Income (2019 - 2026)

Curaleaf Holdings (CURLF) posted quarterly Operating Income of $753000.0 for Q1 2026, down 91.96% year-on-year from $9.4 million in Q1 2025, and down 92.69% on a QoQ basis from $10.3 million in Q4 2025.

Curaleaf Holdings (CURLF) Operating Income (2019 - 2026) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Operating Income for 8 consecutive years, with $753000.0 the latest figure, recorded in Q1 2026.

  • Quarterly Operating Income fell 91.96% year-over-year to $753000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.4 million (down 14.15% YoY) and the FY2025 annual result came in at $25.4 million, up 2.86% from the prior year.
  • Operating Income declined to $753000.0 in Q1 2026 per CURLF's latest filing, from $10.3 million in the prior quarter.
  • Over the last five years, Operating Income for CURLF reached as high as $43.7 million in Q1 2022 and fell as low as -$81.5 million in Q4 2022.
  • A 5-year average of $5.8 million and a median of $7.5 million in 2024 frame the typical range for Operating Income.
  • Annual changes were most pronounced in 2024 — Operating Income sank 34001.34% — and 2025, when it surged 73636.42%.
  • Year by year, Operating Income stood at -$81.5 million in 2022, then jumped by 100.02% to $13967.0 in 2023, then plunged by 34001.34% to -$4.7 million in 2024, then surged by 317.7% to $10.3 million in 2025, then tumbled by 92.69% to $753000.0 in 2026.
  • According to Business Quant data, Operating Income over the past three periods registered $753000.0, $10.3 million, and $4.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 652.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 833.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -2.65 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 325.80 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -79.70 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 193.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 291.00 Mn
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn 753,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 753,000.00
Dec 31, 2025 10.31 Mn
Sep 30, 2025 4.03 Mn
Jun 30, 2025 3.29 Mn
Mar 31, 2025 9.37 Mn
Dec 31, 2024 -4.74 Mn
Sep 30, 2024 9.23 Mn
Jun 30, 2024 7.55 Mn
Mar 31, 2024 12,702.00
Dec 31, 2023 13,967.00
Sep 30, 2023 15.21 Mn
Jun 30, 2023 -4.28 Mn
Mar 31, 2023 17.98 Mn
Dec 31, 2022 -81.53 Mn
Sep 30, 2022 32.51 Mn
Jun 30, 2022 35.10 Mn
Mar 31, 2022 43.73 Mn
Dec 31, 2021 10.49 Mn
Sep 30, 2021 41.60 Mn
Jun 30, 2021 53.37 Mn